Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Long-term persistence in use of statin therapy in elderly patients.

Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J.

JAMA. 2002 Jul 24-31;288(4):455-61.

PMID:
12132975
2.

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.

Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.

Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.

PMID:
19108805
3.

Adherence with statin therapy in elderly patients with and without acute coronary syndromes.

Jackevicius CA, Mamdani M, Tu JV.

JAMA. 2002 Jul 24-31;288(4):462-7.

PMID:
12132976
4.

Long-term adherence to statin treatment in diabetes.

Donnelly LA, Doney AS, Morris AD, Palmer CN, Donnan PT.

Diabet Med. 2008 Jul;25(7):850-5. doi: 10.1111/j.1464-5491.2008.02476.x.

PMID:
18644071
5.

Persistence of use of lipid-lowering medications: a cross-national study.

Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J.

JAMA. 1998 May 13;279(18):1458-62.

PMID:
9600480
6.

Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.

Shalev V, Goldshtein I, Halpern Y, Chodick G.

Pharmacotherapy. 2014 Jan;34(1):1-8. doi: 10.1002/phar.1326. Epub 2013 Jul 8.

PMID:
23836549
7.

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.

Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.

Curr Med Res Opin. 2008 Jul;24(7):1987-2000. doi: 10.1185/03007990802203279 . Epub 2008 Jun 4. Erratum in: Curr Med Res Opin. 2010 Mar;26(3):631.

PMID:
18554430
8.

Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.

Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J.

Eur J Clin Pharmacol. 2005 Oct;61(9):667-74. Epub 2005 Oct 19.

PMID:
16151763
9.

Continuation of statin treatment and all-cause mortality: a population-based cohort study.

Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD.

Arch Intern Med. 2009 Feb 9;169(3):260-8. doi: 10.1001/archinternmed.2008.552.

PMID:
19204217
10.

Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use.

Brookhart MA, Patrick AR, Schneeweiss S, Avorn J, Dormuth C, Shrank W, van Wijk BL, Cadarette SM, Canning CF, Solomon DH.

Arch Intern Med. 2007 Apr 23;167(8):847-52.

PMID:
17452550
11.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
12.

Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, Buda S, Degli Esposti E.

Clin Ther. 2012 Jan;34(1):190-9. doi: 10.1016/j.clinthera.2011.12.011.

PMID:
22284998
13.

Continuation with statin therapy and the risk of primary cancer: a population-based study.

Lutski M, Shalev V, Porath A, Chodick G.

Prev Chronic Dis. 2012;9:E137. doi: 10.5888/pcd9.120005.

15.

Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy.

Benner JS, Pollack MF, Smith TW, Bullano MF, Willey VJ, Williams SA.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1468-75.

PMID:
15998926
16.

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

Wang PS, Solomon DH, Mogun H, Avorn J.

JAMA. 2000 Jun 28;283(24):3211-6.

PMID:
10866868
17.

Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients.

Abughosh SM, Kogut SJ, Andrade SE, Larrat P, Gurwitz JH.

J Manag Care Pharm. 2004 Sep-Oct;10(5):404-11.

18.
19.
20.

Older statin initiators in Finland - cardiovascular risk profiles and persistence of use.

Upmeier E, Korhonen MJ, Rikala M, Helin-Salmivaara A, Huupponen R.

Cardiovasc Drugs Ther. 2014 Jun;28(3):263-72. doi: 10.1007/s10557-014-6517-x.

PMID:
24692150
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk